Results 151 to 160 of about 4,346,534 (345)

Liver hsa-miR-125a-5p and liver HBV-DNA concentration according to demographic, initial biochemical, virological and histological data.

open access: yes, 2013
*Wilcoxon rank test. Footnotes: P-HBV DNA =  Plasma HBV DNA; HAI =  Histological Activity Index; n.v. = normal values.
Gilda Tonziello (430092)   +9 more
core   +1 more source

Diagnostic Performance of cfDNA‐Based Liquid Biopsy for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis

open access: yesCancer Science, EarlyView.
This meta‐analysis demonstrates high diagnostic accuracy of cfDNA‐based liquid biopsy for HCC, with stage‐ and assay‐dependent performance and substantial inter‐study heterogeneity. ABSTRACT Conventional surveillance tools for hepatocellular carcinoma (HCC) have limited sensitivity.
Jiwei Liu   +4 more
wiley   +1 more source

On‐Treatment Reassessment of Type IV Collagen 7S and M2BPGi‐Qt Improves Long‐Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B

open access: yesHepatology Research, EarlyView.
One‐year reassessment of type IV collagen 7S, supported by quantitative M2BPGi‐Qt assessment, helped refine long‐term hepatocellular carcinoma risk stratification in patients with chronic hepatitis B receiving nucleos(t)ide analogue therapy. On‐treatment 4COL7S emerged as a novel marker of residual fibrosis‐related HCC risk.
Kazumi Yamasaki   +9 more
wiley   +1 more source

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients

open access: yesBMC Gastroenterology
Background This multicenter study evaluated serum HBV RNA as a prognostic biomarker for nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB), focusing on correlations with HBV DNA/HBsAg and predictive value for virological response (VR) and ...
Yandi Xie   +14 more
doaj   +1 more source

Primer sequences for detecting HBV DNA and HBV RNA by real-time PCR.

open access: yes
Primer sequences for detecting HBV DNA and HBV RNA by real-time PCR.
Ryo Misaki (280766)   +3 more
core   +1 more source

An Integrative Multi‐Omic Biomarker Panel Distinguishes Hepatocellular Carcinoma From Chronic Liver Disease in HBV‐Predominant Populations

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim DNA methylation is a promising diagnostic biomarker for various cancers including hepatocellular carcinoma (HCC). We aimed to identify aberrant DNA methylation and protein alterations via integrated approaches and develop a highly predictive biomarker panel for blood‐based discrimination of HCC from non‐HCC chronic liver disease (CLD) in ...
Hao Zhuang   +15 more
wiley   +1 more source

Point Prevalence of Hepatitis B Virus Infection among Adolescents in Visakhapatnam, India

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2015
Introduction: Occurrence of detectable amounts of viral antigen or viral particles in the blood of infected patients with Hepatitis B virus (HBV) is a significant characteristic of HBV infection. Detection of HBV antigen or its DNA among individuals of a
Vijayalakshmi Payala   +2 more
doaj  

Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment [PDF]

open access: yes, 2003
Lamivudine treatment in chronic hepatitis B leads to the reconstitution of virus-specific T cells in the circulation, but it is not clear whether this is the preferential result of T cell efflux from the liver or lymph nodes.
Gotto, J   +8 more
core  

ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells

open access: yes, 2022
Hongli Yang,1,* Fajuan Rui,2,* Rui Li,3,* Shengxia Yin,4 Qi Xue,1 Xinyu Hu,5 Yayun Xu,5 Chao Wu,4 Junping Shi,6 Jie Li2,4 1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji’nan ...
Yang H   +9 more
core  

Cyclin‐dependent kinase 4/6 (CDK4/6) inhibitor‐induced hepatotoxicity and its resolution: a study of seven cases

open access: yesHistopathology, EarlyView.
CDK4/6 inhibitor‐induced liver injury represents a clinically significant and histologically distinctive form of drug‐induced hepatotoxicity, most commonly encountered with ribociclib. The predominant pattern is severe acute hepatocellular injury, frequently accompanied by lymphocytic cholangitis, a combination that, in the appropriate clinical context,
Sunayana Misra   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy